Skip to content Skip to global navigation Skip to main navigation Skip to sub navigation Skip to search
NHMRC

CEO congratulates recipient of GlaxoSmithKline Award for Research Excellence

GlaxoSmithKline Award 2012 - Chris Goodnow photoNHMRC congratulates Professor Chris Goodnow for his GlaxoSmithKline Award for Research Excellence to further develop his world-leading research on the cause of autoimmune diseases.

NHMRC is an ongoing supporter of Professor Goodnow research. In 2010 Professor he was awarded a $4 million NHMRC Australia Fellowship to identify the root cause of auto-immune disease. Commencing this year, Professor Goodnow and his team were awarded a $15.7 million NHMRC Program Grant (PDF, 88KB) to research the molecular and cellular basis of inflammatory and immunodeficiency diseases.

For more information on the GlaxoSmithKline Award, visit this website.